Susan Swanezy Sells 15,700 Shares of Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Stock

Vivmark Residential Common Shares of Beneficial Interest (NYSE:VMRK) Director Susan Swanezy sold 15,700 shares of Vivmark Residential Common Shares of Beneficial Interest stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $63.80, for a total value of $1,001,660.00. Following the transaction, the director directly owned 28,934 shares in the company, valued at approximately $1,845,989.20. The trade was a 35.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Vivmark Residential Common Shares of Beneficial Interest Trading Up 0.6%

NYSE VMRK traded up $0.38 on Wednesday, reaching $64.41. The company had a trading volume of 6,131,899 shares, compared to its average volume of 4,406,111. The firm has a market capitalization of $24.15 billion, a P/E ratio of 15.77, a PEG ratio of 5.37 and a beta of 0.73. Vivmark Residential Common Shares of Beneficial Interest has a 52-week low of $57.57 and a 52-week high of $71.50. The company has a current ratio of 0.19, a quick ratio of 0.19 and a debt-to-equity ratio of 0.77.

Vivmark Residential Common Shares of Beneficial Interest News Summary

Here are the key news stories impacting Vivmark Residential Common Shares of Beneficial Interest this week:

• Positive Sentiment: Stifel Nicolaus maintained a “buy” rating and trimmed its price target only slightly, from $79.00 to $78.50. The target remains well above the recent trading level, signaling continued confidence in Vivmark’s potential. Benzinga article
• Positive Sentiment: Evercore initiated coverage with an “in-line” rating and a $72.00 price target. Although not an outright bullish rating, the target indicates potential appreciation and adds institutional research coverage. Tickerreport article
• Positive Sentiment: Zacks Research raised its FY2026 EPS forecast from $4.06 to $4.07, FY2027 EPS from $4.20 to $4.21, and Q1 2027 EPS from $1.00 to $1.02. These increases suggest slightly improved expectations for near- and medium-term profitability.
• Neutral Sentiment: The analyst consensus still projects steady earnings progression, including approximately $4.40 in FY2028 EPS, but the revisions are small and do not represent a major change to Vivmark’s outlook.
• Negative Sentiment: Zacks lowered estimates for Q3 2026, Q2 2027, Q3 2027, Q1 2028, and FY2028. The FY2028 forecast declined from $4.43 to $4.40, indicating modest pressure on longer-term earnings expectations.

Analyst Ratings Changes

Several research firms have commented on VMRK. Stifel Nicolaus decreased their price objective on shares of Vivmark Residential Common Shares of Beneficial Interest from $79.00 to $78.50 and set a “buy” rating for the company in a research note on Wednesday. Evercore began coverage on Vivmark Residential Common Shares of Beneficial Interest in a research report on Tuesday. They set an “in-line” rating and a $72.00 target price on the stock. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Vivmark Residential Common Shares of Beneficial Interest has a consensus rating of “Moderate Buy” and an average price target of $75.25.

About Vivmark Residential Common Shares of Beneficial Interest

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, DC, Seattle, San Francisco, Southern California and Denver.